Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Roweepra vs. Spritam

Are Roweepra and Spritam the Same Thing?

Roweepra (levetiracetam) and Spritam (levetiracetam) are antiseizure (antiepileptic) drugs indicated for adjunctive therapy in the treatment of partial onset seizures in patients with epilepsy, myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.

Side effects of Roweepra and Spritam that are similar include fatigue/tiredness, aggression, runny or stuffy nose decreased appetite, and irritability.

Side effects of Roweepra that are different from Spritam include drowsiness, weakness, infection, and dizziness.

Both Roweepra and Spritam may interact with other drugs.

Antiepileptic drugs, including Roweepra and Spritam, should be withdrawn gradually to minimize the potential of increased seizure frequency.

What Are Possible Side Effects of Roweepra?

Common side effects of Roweepra include:

  • drowsiness,
  • weakness,
  • infection, and
  • dizziness.

Common side effects of Roweepra in children include:

  • fatigue,
  • aggression,
  • stuffy nose,
  • decreased appetite, and
  • irritability.

Antiepileptic drugs (AEDs), including Roweepra, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Tell your doctor if this occurs.

What Are Possible Side Effects of Spritam?

Common side effects of Spritam include:

  • tiredness,
  • decreased appetite,
  • aggression,
  • irritability, and
  • nasal congestion

What Is Roweepra?

Roweepra (levetiracetam) is an antiseizure (antiepileptic) drug indicated for adjunctive therapy in the treatment of partial onset seizures in patients one month of age and older with epilepsy, myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. Roweepra is available in generic form.

What Is Spritam?

Spritam (levetiracetam) is an epilepsy medicine indicated for adjunctive therapy in the treatment of partial onset seizures in patients with epilepsy 4 years of age and older weighing more than 20 kg; myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy; and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. Common side effects of Spritam in adults include sleepiness, weakness, and infection.

SLIDESHOW

What Is Epilepsy? Symptoms, Causes, and Treatments See Slideshow

What Drugs Interact With Roweepra?

Roweepra may interact with other drugs. Tell your doctor all medications and supplements you use.

What Drugs Interact With Spritam?

Spritam may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Spritam; it may harm a fetus. It is recommended that patients be monitored carefully during pregnancy. Spritam passes into breast milk. Breastfeeding while using Spritam is not recommended. Withdrawal seizures may occur if you suddenly stop taking Spritam.

How Should Roweepra Be Taken?

The Roweepra dosing regimen depends on the indication, age group, dosage form (tablets or oral solution), and renal function.

How Should Spritam Be Taken?

The Spritam dosing regimen depends on the indication, age group, and renal function.

QUESTION

If you have had a seizure, it means you have epilepsy. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Reviewed on 10/15/2019
References
Dailymed. Roweepra Product Information

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb66dee6-1d92-4b2d-ae4a-232faf129f24

Aprecia Pharmaceuticals, LLC. Spritam Product Information.

https://www.spritam.com
CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors